Time period and team members: 2-week (two people team) or 4-week (four people team) data collection periods between 18th
GlobalSurg-II: Surgical Site Infection Determining the global epidemiology of surgical site infections after abdominal surgery
Introduction: Surgical site infection (SSI) remains the most common complication following surgery, affecting up to 25% of patients after midline laparotomy. The first GlobalSurg study identified that SSI doubled from high to low-resource countries, even after adjustment for patient risk. Investigating its diagnosis and treatment is a global priority. Eligibility: Any hospital performing intraperitoneal surgery is eligible to participate in GlobalSurg-II. There are no minimum patient numbers per centre, but all consecutive cases must be included. Time period and team members: 2-week (two people team) or 4-week (four people team) data collection periods between 18th January 2016 and 18th July 2016, with 30-day follow-up. Your team chooses a 2-4 week period within this window to run the project at your centre. Multiple periods are encouraged. We hope most centres will participate for 4 weeks; shorter periods (i.e. 2 weeks) are expected to be suitable for elective students on shorter placements, or centres where patient numbers are high (e.g. >50 patients in 2 weeks). Inclusion and Exclusion Criteria § All ages § All consecutive patients undergoing elective or emergency intra-peritoneal surgery with a minimum one-night hospital stay. § Operations may be conducted using an open or laparoscopic approach. § Women undergoing obstetric procedures (including Caesarean Section) are excluded. Audit Standard: Current practice at centres will be audited against the National Institute for Clinical Excellence’s (NICE’s) quality standard 49, which states: § Hospitals and providers of surgery should monitor surgical site infection rates and provide feedback to relevant staff (Quality Statement 7). § People with a surgical site infection are offered treatment with an antibiotic that covers the likely causative organisms (Quality Statement 6). Aims § To determine baseline SSI rates for each participating surgical unit. These will be automatically fed back to collaborators. § Determine local sensitivities and resistance patterns for causative organisms of surgical site infection. § Describe clinical practices associated with SSI. Outcomes: The primary outcome measure is superficial surgical site infection (SSI) at 30 days, defined by the Centre for Disease Control’s definition. The secondary outcome measures at 30-days will be causative pathogens and antibiotic resistance (if these tests are performed), allowing units to audit appropriate antibiotic usage. Authorship: Participation in GlobalSurg projects results in co-authorship on arising publications, with a Pubmed citable ID attributed to all collaborators. Publication will be authored under one main name, (GlobalSurg), representing our group effort. All collaborator names will then be listed at the end of the paper. This authorship model has been successfully used for previous collaborative projects. Register: You may wish to use this summary to begin obtaining approvals in your hospital. A full protocol will be available by September 30th. To register your interest go to http://j.mp/1RuA6BK
@GlobalSurg
www.globalsurg.org
[email protected] 